“Impact of Infections in Patients With Acute Myeloid Leukemia Receiving Cytarabine+ Daunorubicin (7+3) Versus Azacitidine and Venetoclax During Induction Chemotherapy”. 2025. Indus Journal of Bioscience Research 3 (1): 190-96. https://doi.org/10.70749/ijbr.v3i1.469.